Peissenberg, Germany

Johann Karl

USPTO Granted Patents = 39 

 

 

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 103(Granted Patents)


Location History:

  • Weilheim, DE (1990)
  • Peissenberg, DE (1996 - 2024)

Company Filing History:


Years Active: 1990-2025

where 'Filed Patents' based on already Granted Patents

39 patents (USPTO):

Title: The Innovations of Johann Karl: A Pioneer in Biochemical Patents

Introduction

Johann Karl, a prominent inventor based in Peissenberg, Germany, holds an impressive portfolio of 36 patents. His work primarily focuses on biomedical research, showcasing his commitment to innovation in healthcare. He has significantly contributed to developing methods for disease detection and risk assessment, particularly in the realm of stroke prediction and cancer diagnostics.

Latest Patents

Among Johann Karl's latest innovations is a groundbreaking in vitro method for detecting anti-p53 antibodies. This method involves incubating a sample with a p53 capture antigen and a p53 detection antigen, resulting in the formation of a complex that allows for the detection of anti-p53 antibodies in various samples.

Another notable patent highlights his development of methods predicting the risk of stroke by determining the amounts of Angiopoietin-2 (Ang-2) and Insulin-like growth factor-binding protein 7 (IGFBP7) in samples. These patented methods enhance clinical stroke risk assessment and reinforce the significance of biological markers in predicting health outcomes.

Career Highlights

Johann Karl has amassed a wealth of experience through his work with reputable companies such as Roche Diagnostics Operations, Inc. and Boehringer Mannheim GmbH. His contributions in these organizations have propelled advancements in diagnostics and therapeutic interventions, solidifying his status as a leading figure in the field of biomedical research.

Collaborations

Throughout his career, Johann has collaborated with esteemed professionals, including Herbert Andres and Ursula-Henrike Wienhues-Thelen. These partnerships have fostered an environment of innovation and creativity, enabling the development of groundbreaking technologies and methodologies in the biomedical sector.

Conclusion

Johann Karl's dedication to advancing biomedical innovation through his extensive patent portfolio underscores his pivotal role in research and development. His latest inventions reveal a profound impact on healthcare technologies, specifically in diagnostics and predictive analytics. As his work continues to evolve, Johann Karl remains a significant contributor to the future of medical research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…